Notably, Flortaucipir (18F) has shown a good BBB permeability and high affinity for Tau paired helical filament (PHF) aggregates in patients with Alzheimer’s disease [121]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.